HTB news: latest research from CROI 2025, international US aid

LATEST NEWS

Long-awaited results from the RIO study potential of bNAbs to generate vaccine responses to control HIV without ART.

Controversial Spanish study using reduced Biktarvy dosing but with results that support further research in countries threatened with cuts to PEPFAR funding.

PJ results support an upcoming phase 3 PrEP study using lenacapavir once a year.

An introduction to this year’s conference and links to early reports

Local scientists and researchers protest against Trump anti-science policies.

ALL REPORTS

All back issues

Please subscribe to receive a free email every 3-4 weeks of the latest news.

Reports will also be posted to social media at the same time.

Twitter (x)        Facebook        Instagram